Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin - 32 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of August 22, 2025 is 15.98.
  • The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
  • The Amarin 52-week high stock price is 17.49, which is 9.4% above the current share price.
  • The Amarin 52-week low stock price is 7.08, which is 55.7% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 11.71.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 12.0579 10.4720 17.3300 8.0020 15.9800 64.74%
2024 15.5530 17.7840 27.0000 8.8720 9.7000 -44.25%
2023 24.4838 23.8000 43.8000 13.2000 17.4000 -28.10%
2022 39.8223 70.2000 74.6000 21.4000 24.2000 -64.09%
2021 103.0901 100.6000 176.0000 64.8000 67.4000 -31.08%
2020 170.3802 430.6000 430.6000 72.8000 97.8000 -77.19%
2019 364.1571 260.2000 482.4000 252.2000 428.8000 57.53%
2018 144.3048 84.8000 459.6000 49.0000 272.2000 239.40%
2017 66.3661 61.8000 85.8000 57.4000 80.2000 30.19%
2016 46.8516 36.2000 69.4000 25.4000 61.6000 62.96%
2015 40.1429 22.6000 58.0000 20.0000 37.8000 92.92%
2014 30.3917 39.2000 48.0000 16.6460 19.5940 -50.27%
2013 118.2469 162.0000 183.2000 28.0000 39.4000 -75.65%
2012 221.6366 141.0000 309.2000 127.0000 161.8000 8.01%
2011 214.0792 166.6000 390.0000 120.6000 149.8000 -8.67%
2010 53.0791 27.6000 169.8000 19.6000 164.0200 473.54%
2009 23.8716 13.6000 39.0020 10.4000 28.5980 101.39%
2008 38.1171 50.0000 71.7980 12.0000 14.2000 -72.69%
2007 200.1849 436.0000 756.0000 45.0000 52.0000 -88.60%
2006 522.9477 270.0000 748.0000 254.0000 456.0000 90.00%
2005 358.4254 524.0000 680.8000 212.0000 240.0000 -55.72%
2004 277.9263 308.0000 798.0000 106.0000 542.0000 75.97%
2003 580.3368 788.0000 962.0000 278.0000 308.0000 -61.40%
2002 1685.8640 3420.0000 4200.0000 552.0000 798.0000 -77.04%
2001 2692.2460 1100.0000 5594.0000 1000.0000 3475.0000 215.91%
2000 1204.0249 900.0000 1556.2500 750.0000 1100.0000 15.79%
1999 1428.2570 887.5000 2275.0000 825.0000 950.0000 33.33%
1998 2096.1660 6125.0000 6125.0000 200.0000 712.5000 -88.60%
1997 10031.1192 11625.0000 13250.0000 5875.0000 6250.0000 -46.24%
1996 17057.8657 18000.0000 22500.0000 11000.0000 11625.0000 -35.42%
1995 14767.8167 13500.0000 20000.0000 10000.0000 18000.0000 38.46%
1994 15496.5475 17500.0000 21000.0000 9625.0000 13000.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.328B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $249.536B 18.20
Amgen (AMGN) United States $159.226B 13.56
Gilead Sciences (GILD) United States $144.107B 15.01
Vertex Pharmaceuticals (VRTX) United States $101.905B 26.27
Bristol Myers Squibb (BMY) United States $98.576B 7.20
GSK (GSK) United Kingdom $81.670B 9.50
CSL (CSLLY) Australia $69.852B 0.00
Regeneron Pharmaceuticals (REGN) United States $63.397B 15.42
Alnylam Pharmaceuticals (ALNY) United States $61.286B 0.00
Argenex SE (ARGX) Netherlands $40.620B 71.45
Insmed (INSM) United States $28.028B 0.00
BioNTech SE (BNTX) Germany $26.629B 0.00
Royalty Pharma (RPRX) United States $21.175B 8.27
Biogen (BIIB) United States $20.397B 8.69
Incyte (INCY) United States $16.897B 21.52
Genmab (GNMSF) Denmark $16.145B 14.30
Genmab (GMAB) Denmark $15.666B 14.28
Illumina (ILMN) United States $15.261B 23.87
Ascendis Pharma (ASND) Denmark $11.801B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.150B 15.74
QIAGEN (QGEN) Netherlands $10.921B 20.94
Exelixis (EXEL) United States $10.421B 18.79
Swedish Orphan Biovitrum (BIOVF) Sweden $10.313B 22.81
Moderna (MRNA) United States $10.202B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.977B 0.00
Exact Sciences (EXAS) United States $8.837B 0.00
Bio-Techne Corp (TECH) United States $8.465B 31.21
Halozyme Therapeutics (HALO) United States $8.376B 14.73
Roivant Sciences (ROIV) United Kingdom $8.029B 0.00
Guardant Health (GH) United States $7.642B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.311B 39.01
Anbio Biotechnology (NNNN) Germany $7.107B 0.00
Revolution Medicines (RVMD) United States $6.819B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.754B 0.00
Repligen (RGEN) United States $6.731B 73.40
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Legend Biotech (LEGN) United States $6.529B 0.00
Axsome Therapeutics (AXSM) United States $5.845B 0.00
Avidity Biosciences (RNA) United States $5.746B 0.00
Abivax SA (ABVX) France $5.623B 0.00
Nuvalent (NUVL) United States $5.311B 0.00
Merus (MRUS) Netherlands $5.041B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.804B 0.00
Alkermes (ALKS) Ireland $4.797B 13.33
TG Therapeutics (TGTX) United States $4.565B 77.76
Cytokinetics (CYTK) United States $4.553B 0.00
Ascentage Pharma Group - (AAPG) China $4.434B 0.00
Zealand Pharma (ZLDPF) Denmark $4.332B 4.28
Krystal Biotech (KRYS) United States $4.217B 29.61
ACADIA Pharmaceuticals (ACAD) United States $4.182B 38.73
Vaxcyte (PCVX) United States $4.143B 0.00
Telix Pharmaceuticals (TLX) Australia $4.091B 0.00
ADMA Biologics Inc (ADMA) United States $4.081B 29.48
Arcellx (ACLX) United States $3.980B 0.00
PTC Therapeutics (PTCT) United States $3.886B 6.45
Akero Therapeutics (AKRO) United States $3.863B 0.00
Zai Lab (ZLAB) United States $3.776B 0.00
Apellis Pharmaceuticals (APLS) United States $3.488B 0.00
Protagonist Therapeutics (PTGX) United States $3.486B 80.06
MoonLake Immunotherapeutics (MLTX) Switzerland $3.479B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.469B 0.00
Metsera (MTSR) United States $3.446B 0.00
Scholar Rock Holding (SRRK) United States $3.325B 0.00
Jyong Biotech (MENS) Taiwan $3.281B 0.00
Ligand Pharmaceuticals (LGND) United States $3.083B 0.00
Kymera Therapeutics (KYMR) United States $3.045B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.944B 0.00
Bavarian Nordic (BVNRY) Denmark $2.911B 15.38
Viking Therapeutics (VKTX) United States $2.885B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.869B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.845B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.810B 0.00
Immunovant (IMVT) United States $2.587B 0.00
Alvotech (ALVO) Luxembourg $2.554B 19.25
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.489B 839.50
Tarsus Pharmaceuticals (TARS) United States $2.388B 0.00
Liquidia Technologies (LQDA) United States $2.350B 0.00
Amicus Therapeutics (FOLD) United States $2.343B 0.00
Denali Therapeutics (DNLI) United States $2.227B 0.00
Agios Pharmaceuticals (AGIO) United States $2.219B 0.00
IDEAYA Biosciences (IDYA) United States $2.159B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.145B 12.03
Celcuity (CELC) United States $2.137B 0.00
ImmunityBio (IBRX) United States $2.117B 0.00
Disc Medicine (IRON) United States $2.077B 0.00
Belite Bio (BLTE) United States $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.075B 0.00
CG Oncology (CGON) United States $1.981B 0.00
ANI Pharmaceuticals (ANIP) United States $1.978B 17.73
Sarepta Therapeutics (SRPT) United States $1.960B 0.00
Mesoblast (MESO) Australia $1.942B 0.00
Adaptive Biotechnologies (ADPT) United States $1.923B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.893B 0.00
Vericel (VCEL) United States $1.788B 295.33
Certara (CERT) United States $1.730B 31.68
Cidara Therapeutics (CDTX) United States $1.711B 0.00
Apogee Therapeutics (APGE) United States $1.676B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.646B 0.00
Beam Therapeutics (BEAM) United States $1.620B 0.00
Twist Bioscience (TWST) United States $1.598B 0.00
Travere Therapeutics (TVTX) United States $1.586B 0.00
WAVE Life Sciences (WVE) Singapore $1.553B 0.00
Biohaven (BHVN) United States $1.553B 0.00
Edgewise Therapeutics (EWTX) United States $1.540B 0.00
Viridian Therapeutics (VRDN) United States $1.472B 0.00
Celldex Therapeutics (CLDX) United States $1.462B 0.00
Vera Therapeutics (VERA) United States $1.443B 0.00
Janux Therapeutics (JANX) United States $1.442B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.364B 0.00
89BIO (ETNB) United States $1.363B 0.00
Cogent Biosciences (COGT) United States $1.340B 0.00
NovoCure (NVCR) Jersey $1.332B 0.00
AbCellera Biologics (ABCL) Canada $1.285B 0.00
Dynavax Technologies (DVAX) United States $1.284B 54.75
Novavax (NVAX) United States $1.239B 3.35
Pharvaris (PHVS) Netherlands $1.221B 0.00
CureVac (CVAC) Germany $1.216B 5.65
MannKind (MNKD) United States $1.209B 35.82
GRAIL (GRAL) United States $1.195B 0.00
Pacira BioSciences (PCRX) United States $1.141B 12.09
LENZ Therapeutics (LENZ) United States $1.137B 0.00
Structure Therapeutics (GPCR) United States $1.116B 0.00
Arcus Biosciences (RCUS) United States $1.115B 0.00
Intellia Therapeutics (NTLA) United States $1.087B 0.00
Precigen (PGEN) United States $1.085B 0.00
Zymeworks (ZYME) United States $1.082B 0.00
Stoke Therapeutics (STOK) United States $1.078B 23.15
Sionna Therapeutics (SION) United States $1.048B 0.00
MiMedx (MDXG) United States $1.040B 23.43
Spyre Therapeutics (SYRE) United States $1.014B 0.00
CorMedix Inc (CRMD) United States $1.012B 18.08
Praxis Precision Medicines (PRAX) United States $0.976B 0.00
Mineralys Therapeutics (MLYS) United States $0.969B 0.00
Upstream Bio (UPB) United States $0.956B 0.00
Oric Pharmaceuticals (ORIC) United States $0.941B 0.00
Nuvation Bio (NUVB) United States $0.938B 0.00
Iovance Biotherapeutics (IOVA) United States $0.919B 0.00
Urogen Pharma (URGN) United States $0.915B 0.00
Geron (GERN) United States $0.912B 0.00
Trevi Therapeutics (TRVI) United States $0.912B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Pharming Group (PHAR) Netherlands $0.867B 0.00
Immunome (IMNM) United States $0.866B 0.00
Sana Biotechnology (SANA) United States $0.856B 0.00
UniQure (QURE) Netherlands $0.853B 0.00
Anavex Life Sciences (AVXL) United States $0.820B 0.00
ArriVent BioPharma (AVBP) United States $0.807B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.800B 0.00
NeoGenomics (NEO) United States $0.798B 0.00
Tango Therapeutics (TNGX) United States $0.780B 0.00
Niagen Bioscience (NAGE) United States $0.779B 75.15
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.778B 0.00
Oculis Holding AG (OCS) Switzerland $0.777B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.777B 0.00
Dianthus Therapeutics (DNTH) United States $0.761B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.747B 0.00
Nurix Therapeutics (NRIX) United States $0.738B 0.00
BGM Group (BGM) China $0.731B 0.00
Gyre Therapeutics (GYRE) United States $0.727B 151.00
Day One Biopharmaceuticals (DAWN) United States $0.715B 0.00
Zenas BioPharma (ZBIO) United States $0.713B 0.00
Fortrea Holdings (FTRE) United States $0.703B 12.49
Ginkgo Bioworks Holdings (DNA) United States $0.696B 0.00
Arbutus Biopharma (ABUS) United States $0.686B 0.00
Immatics (IMTX) Germany $0.684B 0.00
GH Research (GHRS) Ireland $0.676B 0.00
Kura Oncology (KURA) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Bicara Therapeutics (BCAX) United States $0.635B 0.00
MeiraGTx Holdings (MGTX) United States $0.632B 0.00
Tyra Biosciences (TYRA) United States $0.624B 0.00
Keros Therapeutics (KROS) United States $0.616B 48.94
Vir Biotechnology (VIR) United States $0.608B 0.00
Rezolute (RZLT) United States $0.605B 0.00
Terns Pharmaceuticals (TERN) United States $0.592B 0.00
Maze Therapeutics (MAZE) United States $0.580B 0.00
Castle Biosciences (CSTL) United States $0.579B 57.06
AnaptysBio (ANAB) United States $0.570B 0.00
Palvella Therapeutics (PVLA) United States $0.567B 0.00
Rapport Therapeutics (RAPP) United States $0.545B 0.00
Myriad Genetics (MYGN) United States $0.542B 0.00
Arvinas (ARVN) United States $0.536B 0.00
Verastem (VSTM) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Septerna (SEPN) United States $0.522B 0.00
Kodiak Sciences (KOD) United States $0.513B 0.00
Cytek Biosciences (CTKB) United States $0.510B 0.00
Emergent Biosolutions (EBS) United States $0.497B 4.07
Gossamer Bio (GOSS) United States $0.493B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.491B 0.00
ATyr Pharma (ATYR) United States $0.485B 0.00
Alumis (ALMS) United States $0.479B 0.00
MBX Biosciences (MBX) United States $0.475B 0.00
Tectonic Therapeutic (TECX) United States $0.475B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.475B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.466B 0.00
Prothena (PRTA) Ireland $0.461B 0.00
Eton Pharmaceuticals (ETON) United States $0.458B 0.00
Cullinan Therapeutics (CGEM) United States $0.453B 0.00
ITeos Therapeutics (ITOS) United States $0.451B 0.00
PureTech Health (PRTC) United States $0.444B 0.00
Solid Biosciences (SLDB) United States $0.441B 0.00
Replimune (REPL) United States $0.437B 0.00
Prime Medicine (PRME) United States $0.433B 0.00
Erasca (ERAS) United States $0.426B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.425B 0.00
REGENXBIO (RGNX) United States $0.410B 0.00
Inventiva S.A (IVA) France $0.408B 0.00
Kamada (KMDA) Israel $0.405B 20.72
Rocket Pharmaceuticals (RCKT) United States $0.402B 0.00
Aura Biosciences (AURA) United States $0.402B 0.00
XOMA Royalty (XOMA) United States $0.396B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.394B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.388B 0.00
Compass Therapeutics (CMPX) United States $0.387B 0.00
I-Mab (IMAB) United States $0.385B 0.00
Absci (ABSI) United States $0.383B 0.00
Olema Pharmaceuticals (OLMA) United States $0.380B 0.00
Northwest Biotherapeutics (NWBO) United States $0.368B 0.00
Abeona Therapeutics (ABEO) United States $0.365B 7.73
Astria Therapeutics (ATXS) United States $0.358B 0.00
Fulcrum Therapeutics (FULC) United States $0.353B 0.00
Inhibrx Biosciences (INBX) United States $0.350B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.349B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 3.62
Benitec Biopharma (BNTC) United States $0.333B 0.00
Candel Therapeutics (CADL) United States $0.318B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.316B 0.00
DiaMedica Therapeutics (DMAC) United States $0.307B 0.00
Bright Minds Biosciences (DRUG) United States $0.297B 0.00
Ocugen (OCGN) United States $0.295B 0.00
Design Therapeutics (DSGN) United States $0.293B 0.00
Cartesian Therapeutics (RNAC) United States $0.285B 0.00
Foghorn Therapeutics (FHTX) United States $0.285B 0.00
Neurogene (NGNE) United States $0.282B 0.00
Contineum Therapeutics (CTNM) United States $0.282B 0.00
Crescent Biopharma (CBIO) United States $0.282B 0.00
Atea Pharmaceuticals (AVIR) United States $0.280B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.278B 12.50
Vor Biopharma (VOR) $0.275B 0.00
Lifecore Biomedical (LFCR) United States $0.270B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 0.00
Neumora Therapeutics (NMRA) United States $0.266B 0.00
Puma Biotechnology (PBYI) United States $0.263B 5.33
Mereo BioPharma Group - (MREO) United Kingdom $0.262B 0.00
DBV Technologies S.A (DBVT) France $0.261B 0.00
Codexis (CDXS) United States $0.255B 0.00
Tvardi Therapeutics (TVRD) United States $0.250B 0.00
Allogene Therapeutics (ALLO) United States $0.249B 0.00
Editas Medicine (EDIT) United States $0.245B 0.00
ScPharmaceuticals (SCPH) United States $0.244B 0.00
Jade Biosciences (JBIO) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Alpha Teknova (TKNO) United States $0.240B 0.00
Humacyte (HUMA) United States $0.239B 0.00
Annexon (ANNX) United States $0.238B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.233B 0.00
Alector (ALEC) United States $0.230B 0.00
Adherex Technologies (FENC) United States $0.227B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.226B 0.00
Sagimet Biosciences (SGMT) United States $0.225B 0.00
Entrada Therapeutics (TRDA) United States $0.223B 0.00
Adocia (ADOCY) France $0.216B 0.00
Aardvark Therapeutics (AARD) United States $0.211B 0.00
AC Immune (ACIU) Switzerland $0.211B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
Innate Pharma S.A (IPHA) France $0.206B 0.00
EnGene Holdings (ENGN) Canada $0.200B 0.00
Monopar Therapeutics (MNPR) United States $0.196B 0.00
Tenaya Therapeutics (TNYA) United States $0.189B 0.00
Ventyx Biosciences (VTYX) United States $0.189B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.187B 0.00
Elicio Therapeutics (ELTX) United States $0.187B 0.00
Voyager Therapeutics (VYGR) United States $0.186B 0.00
C4 Therapeutics (CCCC) United States $0.186B 0.00
SELLAS Life Sciences (SLS) United States $0.185B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.184B 0.00
Instil Bio (TIL) United States $0.179B 0.00
Rapt Therapeutics (RAPT) United States $0.177B 0.00
Sangamo Therapeutics (SGMO) United States $0.173B 0.00
Caribou Biosciences (CRBU) United States $0.171B 0.00
Immuneering (IMRX) United States $0.168B 0.00
Tevogen Bio Holdings (TVGN) United States $0.166B 0.00
Nkarta (NKTX) United States $0.165B 0.00
Greenwich LifeSciences (GLSI) United States $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.161B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
Seres Therapeutics (MCRB) United States $0.160B 0.00
Actuate Therapeutics (ACTU) United States $0.159B 0.00
Kyverna Therapeutics (KYTX) United States $0.155B 0.00
Black Diamond Therapeutics (BDTX) United States $0.154B 11.78
Cellectis S.A (CLLS) France $0.154B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.153B 0.00
MaxCyte (MXCT) United States $0.151B 0.00
Cardiff Oncology (CRDF) United States $0.150B 0.00
BioHarvest Sciences (BHST) Canada $0.149B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Climb Bio (CLYM) United States $0.148B 0.00
Cabaletta Bio (CABA) United States $0.146B 0.00
Cognition Therapeutics (CGTX) United States $0.146B 0.00
TuHURA Biosciences (HURA) United States $0.146B 0.00
Agenus (AGEN) United States $0.146B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.143B 0.00
Forte Biosciences (FBRX) United States $0.138B 0.00
Zura Bio (ZURA) United States $0.136B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.135B 0.00
Alpha Cognition (ACOG) Canada $0.133B 0.00
Coherus Oncology (CHRS) United States $0.131B 0.00
Anika Therapeutics (ANIK) United States $0.130B 0.00
Genelux (GNLX) United States $0.130B 0.00
Fate Therapeutics (FATE) United States $0.128B 0.00
Citius Oncology (CTOR) United States $0.128B 0.00
Compugen (CGEN) Israel $0.128B 0.00
Scilex Holding (SCLX) United States $0.119B 0.00
IO Biotech (IOBT) Denmark $0.117B 0.00
Seer (SEER) United States $0.116B 0.00
Coya Therapeutics (COYA) United States $0.110B 0.00
Skye Bioscience (SKYE) United States $0.110B 0.00
Adagene (ADAG) China $0.107B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Biomea Fusion (BMEA) United States $0.107B 0.00
Spero Therapeutics (SPRO) United States $0.105B 0.00
23andMe Holding (MEHCQ) United States $0.104B 0.00
HilleVax (HLVX) United States $0.104B 0.00
Inovio Pharmaceuticals (INO) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.101B 0.00
BioStem Technologies (BSEM) $0.100B 5.23
TScan Therapeutics (TCRX) United States $0.098B 0.00
XBiotech (XBIT) United States $0.098B 0.00
Alto Neuroscience (ANRO) United States $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.096B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.095B 0.00
VistaGen Therapeutics (VTGN) United States $0.094B 0.00
Immunic (IMUX) United States $0.093B 0.00
Equillium (EQ) United States $0.093B 0.00
Elutia (ELUT) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Pliant Therapeutics (PLRX) United States $0.089B 0.00
OKYO Pharma (OKYO) $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Celularity (CELU) United States $0.086B 0.00
CervoMed (CRVO) United States $0.085B 0.00
Nautilus Biotechnology (NAUT) United States $0.084B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.082B 0.00
Atara Biotherapeutics (ATRA) United States $0.081B 0.00
EXoZymes (EXOZ) United States $0.078B 0.00
Whitehawk Therapeutics (WHWK) United States $0.078B 0.00
BioXcel Therapeutics (BTAI) United States $0.076B 0.00
Applied Therapeutics (APLT) United States $0.074B 0.00
Sutro Biopharma (STRO) United States $0.072B 0.00
ABVC BioPharma (ABVC) United States $0.072B 0.00
BeyondSpring (BYSI) United States $0.071B 0.00
Opus Genetics (IRD) United States $0.069B 0.00
TELA Bio (TELA) United States $0.068B 0.00
Ovid Therapeutics (OVID) United States $0.068B 0.00
Artiva Biotherapeutics (ARTV) United States $0.068B 0.00
MiNK Therapeutics (INKT) United States $0.068B 0.00
Genenta Science S.p.A (GNTA) Italy $0.067B 0.00
Fortress Biotech (FBIO) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.067B 0.00
Immix Biopharma (IMMX) United States $0.066B 0.00
ZIVO Bioscience (ZIVO) United States $0.066B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.065B 0.00
Invivyd (IVVD) United States $0.063B 0.00
MediciNova (MNOV) United States $0.063B 0.00
INmune Bio (INMB) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Cue Biopharma (CUE) United States $0.062B 0.00
Adverum Biotechnologies (ADVM) United States $0.061B 0.00
Aligos Therapeutics (ALGS) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
KALA BIO (KALA) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
Adicet Bio (ACET) United States $0.057B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
ImageneBio (IMA) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
ALX Oncology Holdings (ALXO) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.054B 0.00
Clene (CLNN) United States $0.053B 0.00
Quantum Biopharma (QNTM) Canada $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.048B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.047B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.046B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Lantern Pharma (LTRN) United States $0.045B 0.00
Alterity Therapeutics - (ATHE) Australia $0.045B 0.00
Radiopharm Theranostics - (RADX) Australia $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
Medicus Pharma (MDCX) United States $0.044B 0.00
Shattuck Labs (STTK) United States $0.043B 0.00
Generation Bio (GBIO) United States $0.042B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
PepGen (PEPG) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.041B 0.00
Mersana Therapeutics (MRSN) United States $0.040B 0.00
Rani Therapeutics Holdings (RANI) United States $0.039B 0.00
Renovaro (RENB) United States $0.039B 0.00
Exicure (XCUR) United States $0.039B 0.00
CalciMedica (CALC) United States $0.039B 0.00
Pluri (PLUR) Israel $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.037B 0.00
X4 Pharmaceuticals (XFOR) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.028B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.027B 0.00
Rein Therapeutics (RNTX) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Rallybio (RLYB) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.024B 0.00
Passage Bio (PASG) United States $0.024B 0.00
Tharimmune (THAR) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.023B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.023B 0.00
Synaptogenix (TAOX) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
Femasys (FEMY) United States $0.018B 0.00
Moleculin Biotech (MBRX) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.018B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Chemomab Therapeutics (CMMB) Israel $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.015B 0.00
Intensity Therapeutics (INTS) United States $0.015B 0.00
Soligenix (SNGX) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.011B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
IN8bio (INAB) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Aptevo Therapeutics (APVO) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Palisade Bio (PALI) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
BRIACELL THERAP (BCTX) Canada $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00